33307021
2020 Dec 8
Nonalcoholic fatty liver disease. (NAFLD) is a leading etiology for chronic liver disease with global public health impact, affecting over 25% of the global population. NAFLD is associated with significant morbidity and mortality from cirrhosis, hepatocellular carcinoma (HCC), solid organ malignancies, diabetes mellitus, cardiovascular disease, and obstructive sleep apnea, resulting in significant healthcare resource utilization and decreased health-related quality of life. NAFLD cirrhosis is a leading indication for liver transplantation in the United States. Lifestyle modification to achieve weight loss remains a first line intervention in patients with NAFLD. Herein we summarize evidence-based interventions for lifestyle modification in the treatment of NAFLD and provide Best Practice Advice (BPA) statements to address key issues in clinical management.
NASH; cirrhosis; diet; exercise; fatty liver; liver fibrosis; obesity; steatohepatitis; weight loss.
